证券记录 · 已归档季度
DNA
Ginkgo Bioworks Holdings, Inc. · Healthcare · Biotechnology
15被追踪持有人
-2Δ持有人
16.22M持有股份
$236.55M报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -11.8% ·
股份流向 -5.5% ·
净新建仓位 -13.3%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +5 | 25.52M | $252.75M | +9 | −4 |
| Q1 2026 | 72 | -1 | 23.15M | $141.95M | +6 | −7 |
| Q4 2025 | 73 | +2 | 24.08M | $200.09M | +2 | — |
| Q3 2025 | 15 | -2 | 16.22M | $236.55M | — | −2 |
| Q2 2025 | 14 | 0 | 15.99M | $179.94M | +2 | −2 |
| Q1 2025 | 11 | -3 | 10.22M | $58.26M | — | −3 |
| Q4 2024 | 14 | +3 | 10.20M | $100.21M | +3 | — |
| Q3 2024 | 10 | -3 | 9.70M | $79.02M | — | −3 |
| Q2 2024 | 13 | — | 419.17M | $140.02M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 3.58M | 0.0% | $52.15M | 0.1% | Held | 6 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 3.42M | +12.1% | $49.83M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 3.24M | -1.2% | $47.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 3.24M | -1.2% | $47.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Baillie Gifford ✦ | 3.24M | -1.2% | $47.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 3.24M | -1.2% | $47.17M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | The Vanguard Group ✦ (被动) | 2.48M | +4.2% | $36.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 2.48M | +4.2% | $36.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (被动) | 2.48M | +4.2% | $36.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | The Vanguard Group ✦ (被动) | 2.48M | +4.2% | $36.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | The Vanguard Group ✦ (被动) | 2.48M | +4.2% | $36.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | The Vanguard Group ✦ (被动) | 2.48M | +4.2% | $36.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (被动) | 933.84K | +26.0% | $13.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 825.29K | — | $12.03M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 825.29K | — | $12.03M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Geode Capital Management ✦ (被动) | 808.36K | -13.8% | $11.79M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Geode Capital Management ✦ (被动) | 808.36K | -13.8% | $11.79M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Morgan Stanley ✦ | 320.72K | — | $4.68M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Two Sigma Investments ✦ | 174.66K | -14.2% | $2.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 150.69K | -8.0% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 150.69K | -8.0% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 150.69K | -8.0% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 150.69K | -8.0% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 150.69K | -8.0% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 44 | Glenview Capital ✦ | 149.38K | 0.0% | $2.18M | 0.1% | Held | 6 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 93.00K | +5.8% | $1.36M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | T. Rowe Price ✦ | 93.00K | +5.8% | $1.36M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 31.55K | — | $460,056 | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Millennium Management ✦ | 22.86K | -98.3% | $333,357 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 56 | Fidelity (FMR) ✦ | 2.74K | +9.1% | $40,008 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 57 | Fidelity (FMR) ✦ | 2.74K | +9.1% | $40,008 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| D. E. Shaw & Co. | $672,424 | 曾为 0.0% |
| Citadel Advisors | $113,783 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 140 股份, $0 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 24
Coen Steven P.
Officer · 330 股 · $2,302
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Jul 30
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据